Christopher deBorde

Company: Century Therapeutics

Job title: Process Development Engineer

Seminars:

Starting Material Considerations for iPSC-Derived Cell Products 2:00 pm

Utilizing a risk-based approach to address starting materials, donor eligibility, cell banking and genetic stability Implementing phase-appropriate cell collection processes to obtain consistent, compliant, and high-quality starting materials Interpreting FDA cGMP guidance for Phase 1 investigational drugsRead more

day: Conference Day One

Panel Discussion: Recognizing the Importance of Quality Starting Material for the Downstream Process 2:30 pm

How do we reconcile the jump from healthy donor to clinical patient material? How selective should we be with the starting cell populations? How does cellular starting material variability impact downstream product quality? Read more

day: Conference Day One